J B Chemicals & Pharmaceuticals Ltd Financial Ratios
JBCHEPHARM · Healthcare · Current price ₹2,408.9
P/E ratio
53.3x
P/B ratio
9.3x
ROE
17.1%
ROCE
23.0%
Debt / Equity
0.00
Dividend yield
0.9%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 53.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 9.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 17.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 23.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.00 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with J B Chemicals & Pharmaceuticals Ltd's latest numbers.
J B Chemicals & Pharmaceuticals Ltd profitability
J B Chemicals & Pharmaceuticals Ltd generates a return on equity of 17.1% and a return on capital employed of 23.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.00 and a P/E of 53.3x, J B Chemicals & Pharmaceuticals Ltd is conservatively financed. Our overall business-quality score for the company is 5.6 / 10.
Understand the ratios
More on J B Chemicals & Pharmaceuticals Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.